OBJECTIVE: To determine whether the introduction of a postpartum hemorrhage (PPH) patient safety program was associated with changes in patient care or outcomes. STUDY DESIGN: A multipronged patient safety program regarding PPH was instituted at a tertiary care maternity hospital. Patient care and outcomes were assessed for 6 months prior to (period A) and 6 months after (period B) program institution. RESULTS: In all, 278 and 341 women were diagnosed with PPH during periods A and B, respectively. Women who had a PPH after the program were more likely to receive more than one dose of prostaglandin F2 α (24% versus 9%, p = 0.01) and more than one type of uterotonic (34% versus 25%, p = 0.02) and to have a B-lynch suture placed (9.4% versus 4.7%, p = 0.03). The frequency of blood transfusion, hysterectomy, and intensive care unit admission were similar between periods. CONCLUSION: Introduction of a PPH safety program resulted in several indications of a more quickly escalated response. Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.
OBJECTIVE: To determine whether the introduction of a postpartum hemorrhage (PPH) patient safety program was associated with changes in patient care or outcomes. STUDY DESIGN: A multipronged patient safety program regarding PPH was instituted at a tertiary care maternity hospital. Patient care and outcomes were assessed for 6 months prior to (period A) and 6 months after (period B) program institution. RESULTS: In all, 278 and 341 women were diagnosed with PPH during periods A and B, respectively. Women who had a PPH after the program were more likely to receive more than one dose of prostaglandin F2 α (24% versus 9%, p = 0.01) and more than one type of uterotonic (34% versus 25%, p = 0.02) and to have a B-lynch suture placed (9.4% versus 4.7%, p = 0.03). The frequency of blood transfusion, hysterectomy, and intensive care unit admission were similar between periods. CONCLUSION: Introduction of a PPH safety program resulted in several indications of a more quickly escalated response. Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.
Authors: Homa K Ahmadzia; Jaclyn M Phillips; Rose Kleiman; Alexis C Gimovsky; Susan Bathgate; Naomi L C Luban; Richard L Amdur Journal: Am J Perinatol Date: 2020-05-23 Impact factor: 3.079
Authors: Fernando Althabe; Michelle N S Therrien; Veronica Pingray; Jorge Hermida; Ahmet M Gülmezoglu; Deborah Armbruster; Neelima Singh; Moytrayee Guha; Lorraine F Garg; Joao P Souza; Jeffrey M Smith; Beverly Winikoff; Kusum Thapa; Emmanuelle Hébert; Jerker Liljestrand; Soo Downe; Ezequiel Garcia Elorrio; Sabaratnam Arulkumaran; Emmanuel K Byaruhanga; David M Lissauer; Monica Oguttu; Alexandre Dumont; Maria F Escobar; Carlos Fuchtner; Pisake Lumbiganon; Thomas F Burke; Suellen Miller Journal: Int J Gynaecol Obstet Date: 2019-12-23 Impact factor: 3.561
Authors: Emer L Colalillo; Andrew D Sparks; Jaclyn M Phillips; Chinelo L Onyilofor; Homa K Ahmadzia Journal: Sci Rep Date: 2021-07-19 Impact factor: 4.379